CurveBeam Receives FDA 510(k) Approval for the pedCAT 3D Foot and Ankle Scanner

CurveBeam has announced it has received FDA 510(k) approval for pedCAT, an in-office 3D foot and ankle scanner, according to a news release from CurveBeam.

Advertisement

 

pedCAT uses cone Beam Computed Tomography technology to produce images of the foot and ankle region under true physiological weight-bearing conditions, according to the company.

“We are introducing this first of its kind modality to podiatric surgeons and orthopedic foot & ankle specialists with tremendous excitement and anticipation,” said Arun Singh, CEO of CurveBeam, in the release. “pedCAT will give physicians immediate access to more precise and detailed views of foot conditions, and that will optimize their treatment planning for greater predictability of surgical outcomes.”

 

CurveBeam is based out of Warrington, Pa.

 

Related Articles on FDA Clearances:

NeuroMetrix Seeks FDA Approval for New Pain Therapy Device

Sotera Wireless Receives FDA 510(k) Clearance for ViSi Mobile Vital Signs Monitoring System

Devon Medical Products Receives FDA 510(k) Clearance for extriCARE 2400 Negative Pressure Wound Therapy System

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

  • Across the country, states are rewriting the rules for certified registered nurse anesthetists, shifting away from physician supervision requirements and…

  • As the ASC industry continues to grow alongside new waves of surgical innovation, patient preferences and shifts to value-based care,…

  • A Pleasant View, Utah-based physician has been indicted on charges of obtaining unapproved drugs from China and selling them to…

Advertisement

Comments are closed.